Informatie:
Fout:
ID
22666
Beschrijving
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00600587
Link
https://clinicaltrials.gov/show/NCT00600587
Trefwoorden
Versies (1)
- 09-06-17 09-06-17 -
Geüploaded op
9 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587
Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
ID.2
Item
histological or cytological documented
boolean
C0449575 (UMLS CUI [1,1])
C0205471 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
C0205471 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
ID.3
Item
resectable nsclc of stage iiia-n2 confirmed by mediastinoscopy or pet
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C1300072 (UMLS CUI [1,2])
ID.4
Item
naive therapy nsclc
boolean
C0919936 (UMLS CUI [1])
ID.5
Item
candidates should be tolerated with induction therapy and thoracotomy with ecog performance status 0-2, adequate haematological and hepatic- renal function and qualified lung function
boolean
C1520224 (UMLS CUI [1,1])
C0678852 (UMLS CUI [1,2])
C0857127 (UMLS CUI [1,3])
C0678852 (UMLS CUI [1,2])
C0857127 (UMLS CUI [1,3])
ID.6
Item
enough tissue samples to perform gene analysis
boolean
C3267141 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0475358 (UMLS CUI [1,2])
ID.7
Item
small cell lung cancer
boolean
C0149925 (UMLS CUI [1])
ID.8
Item
pregnant or breast-feeding women
boolean
C0549206 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.9
Item
any unstable systemic disease
boolean
C1385002 (UMLS CUI [1])
ID.10
Item
patients with exposure to investigational drug therapy or other concurrent anticancer therapy outside of this trial
boolean
C0008976 (UMLS CUI [1])